Antihypertensive agents & angina pectoris Flashcards
Systolic blood pressure of 140 or greater or diastolic blood pressure of 90 or greater.
Risk factors:
•Smoking
•Metabolic syndrome
•Manifestations of end organ damage at the time of diagnosis
•Family history
HYPERTENSION
Classification of Hypertension:
<120/80 - Normal
120-139/80-89 - Prehypertension
>= 140/90 - Hypertension
140-159/90-99 - Stage 1
>=160/100 - Stage 2
Hypertension Etiology
Essential/primary Hypertension
Secondary Hypertension
Contributing Factors:
- Genetic factors
- Physiological stress
- Environmental & dietary factors
Anatomic sites of blood pressure control
- Resistance - Arterioles
- Capacitance - Venules
- Pump output - Heart
- Volume - Kidneys
BASIC PHARMACOLOGY OF ANTIHYPERTENSIVE AGENTS:
•DRUGS THAT ALTERS SODIUM & WATER BALANCE: DIURETICS
•DRUGS THAT ALTER SYMPATHETIC NERVOUS SYSTEM FUNCTION: SYMPATHOPLEGIC AGENTS
•DIRECT VASODILATORS:
•AGENTS THAT BLOCK PRODUCTION OR ACTION OF ANGIOTENSIN
- lowers BP by depleting the body of sodium stores and reducing blood volume or other mechanisms.
- Increase urine excretion
- Reduce the circulating fluid volume to treat edema and hypertension.
Agents used:
Thiazide
Loop diuretics
Potassium-sparing diuretics
Osmotic diuretics
DIURETICS
- For mild to moderate hypertension and normal renal and cardiac function.
•Hydrochlorothiazide
•Chlorthalidone
Uses:
-Hypertension
-Edema
-Prophylaxis of calculu formation
Side effects:
-Hypokalemia
-Muscle weakness
-Postural hypotension Hyperglycemia
-Increase uric acid level
Thiazides (Diuretics)
-Acts directly on the loop of Henle in the kidney to inhibit sodium and chloride reabsorption which in turn inhibits water reabsorption back into the bloodstream leading to increased urine formation.
• Furosemide
• Bumetanide
Uses:
-Edema
-Pulmonary edema
-Ascites
-Hypertension combined with antihypertensives especially in patients with kidney disease.
Side Effects:
-Fluid & electrolyte imbalance -Hypotension
-Hyperglycemia & increase uric
acid level
Loop Diuretics
-Prevent potassium depletion and enhance the natriuretic effects of other diuretics,
-Counteracts the increase of glucose and uric acid levels
•Spironolactone
•Triamterene
Uses:
-Used in combination with thiazide diuretics
-To increase the diuretic and hypotensive effects and reduce the dangers of hyperkalemia.
Side Effects:
Hyperkalemia
Fatigue, lethargy
Hypotension
Gynecomastia
Potassium-Sparing Diuretics
- Used to reduce intracranial pressure (ICP) or intraocular pressure (IOP). - Used in emergency cases that involves cranial or spinal trauma & used to reduce the risk ofnnervous system damage from swelling.
• Mannitol
Side Effects:
- fluid & electrolyte imbalance
- CNS symptoms
- Gl symptoms
- Tachycardia
- Allergic reactions
- Pulmonary edema
Osmotic Diuretics
- Used for the treatment of hypertension during pregnancy.
-Lowers BP by reducing peripheral vascular resistance with a variable reduction in heart rate and cardiac output.
Pharmacokinetics:
half-life: 2 hours
bioavailability: 25%
initial dose: 1g/day
Toxicity:
Sedation
Mental lassitude & impaired mental
concentration.
Nightmares
Mental depression
Vertigo
EPS
Methyldopa (CENTRALLY ACTING SYMPATHOPLEGIC DRUGS)
- used in the treatment of hypertension.
- Lowers BP in the supine position and rarely causes postural hypotension.
Pharmacokinetics:
half-life: 8-12 hours
bioavailability: 95%
initial dose: 0.2mg/day
Toxicity:
- Dry mouth
- Sedation
- Nervousness
- Tachycardia
- H/A
- Sweating
Clonidine (CENTRALLY ACTING SYMPATHOPLEGIC DRUGSl
- Inhibits the release of norepinephrine from the sympathetic nerve endings.
- It replaces norepinephrine and causes a gradual depletion of norepinephrine stores in the nerve endings.
-It interferes with amine release. - Half-life: 5 days
Toxicity:
Symptomatic postural hypotention Delayed or retrograde ejaculation
Diarrhea
Guanethidine (ADRENERGIC NEURON-BLOCKING AGENTS)
-Blocks the ability of aminergic transmitter vesicle to take up & store biogenic amines by interfering with the vesicular membrane associated transporter (VMAT).
-Half-Life: 24-48 hours
-Bioavailability: 50%
-Initial dose: 0.25mg/day
Toxicity:
- Sedation
- Lassitude
- Nightmares
- Severe mental depression
Reserpine (ADRENERGIC NEURON-BLOCKING AGENTS)
- Decreases BP primarily as a result of a decrease in cardiac output.
- Inhibits the stimulation of renin production by caatecholamines.
- Most effective in patients with high plasma renin activity.
Half-life: 3-5 hours
Bioavailability: 25%
Initial dose: 80mg/day
Propranolol (BETA-ADRENOCEPTOR-BLOCKING AGENTS)
- Less bronchial constriction than propranolol at doses that produce equal inhibition of B-adrenoceptor responses.
- Metabolized by CYP2D6 with high first-pass metabolism.
Half-life: 4-6 hours
METOPROLOL (BETA-ADRENOCEPTOR-BLOCKING AGENTS)
- Less effective than metoprolol in preventing complications of hypertensions
Half-life: 6 hours
Patients with reduced renal functions should receive lower doses.
ATENOLOL (BETA-ADRENOCEPTOR-BLOCKING AGENTS)
-Non selective B-receptor antagonist. -Not metabolized & excreted in the urine.
Nadolol & Carteolol (BETA-ADRENOCEPTOR-BLOCKING AGENTS)
- B1-selective blockers
- Primary metabolized in the liver.
Betaxolol & Bisoprolol (BETA-ADRENOCEPTOR-BLOCKING AGENTS)
- These drugs are partial agonist
-Lowers BP but they are rarely used in HPN.
Pindolol, Acebutolol, & Penbutolol (BETA-ADRENOCEPTOR-BLOCKING AGENTS)
- Labetalol is useful in the treatment of hypertension of pheochromocytoma & hypertensive emergencies. Formulated as a racemic mixture of 4 isomers.
- Carvedilol also administered as a racemic mixture. With a half-life of 7-10 hours.
- Nebivolol is a B1-selective blocker & vasodilating property that is not mediated by alpha blockade, with a half-life of 10-12 hours.
Labetalol, Carvedilol, & Nebivolol (BETA-ADRENOCEPTOR-BLOCKING AGENTS)
- A BI-selective blocker, rapidly metabolized via hydrolysis by RBC esterases.
- Short half-life: 9-10 minutes
- Administered through IV infusion
Esmolol (BETA-ADRENOCEPTOR-BLOCKING AGENTS)
- Produces their antihypertensive effects by selectively blocking alpha I receptors in arterioles & venules.
- Reduces arterial pressure by dilating both resistance & capacitance vessels.
- More effective when used in combination with B-blockers & a diuretic.
Uses:
- Prostatic hyperplasia
- Bladder obstruction symptoms
- Hypertension
- BPH
Toxicity:
Dizziness
Palpitations
H/A
Lassitude
Prazosin, Terazosin & Doxazosin (ALPHA I BLOCKERS)
- Nonselective agents
- Used in diagnosis & treatment of PHEOCHROMOCYTOMA & in other clinical situations.
- used in the treatment of clonidine withdrawal syndrome in combination with B-blockers.
Phentolamine & Phenoxybenzamine (ALPHA ADRENOCEPTOR-BLOCKING AGENTS)